PANGEA-HIV: Phylogenetics for generalised epidemics in Africa

The Lancet Infectious Diseases

Volumn 15, Issue 3, 2015, Pages 259-261

  Pillay, Deenan ^a   Herbeck, Joshua ^c   Cohen, Myron S ^d   Oliveira, Tulio de ^a,b   Fraser, Christophe ^e   Ratmann, Oliver ^e   Brown, Andrew Leigh ^f   Kellam, Paul ^g  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; BEHAVIOR CHANGE; DEVELOPING COUNTRY; EPIDEMIC; GENE SEQUENCE; HEALTH CARE ORGANIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PRE-EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; PUBLIC HEALTH; SOUTHERN AFRICAN; CLASSIFICATION; GENETICS; GENOTYPE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; PROCEDURES; VIROLOGY;

AFRICA; EPIDEMICS; GENOTYPE; HIV; HIV INFECTIONS; HUMANS; MOLECULAR EPIDEMIOLOGY; PHYLOGENY;

EID: 84923219616     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)70036-8     Document Type: Note

References (15)

1. Bor J, Herbst AJ, Newell ML, Barnighausen T Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 2013, 339:961-965.
2. Zaidi J, Grapsa E, Tanser F, Newell ML, Barnighausen T Dramatic increases in HIV prevalence after scale-up of antiretroviral treatment: a longitudinal population-based HIV surveillance study in rural Kwazulu-Natal. AIDS 2013, 27:2301-2305.
3. Joint United Nations Programme on HIV/AIDS. UNAIDS World AIDS Day report 2012, UNAIDS, Joint United Nations Programme on HIV/AIDS, Geneva.
4. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011, 365:493-505.
5. Tanser F, de Oliveira T, Maheu-Giroux M, Barnighausen T Concentrated HIV subepidemics in generalized epidemic settings. Curr Opin HIV AIDS 2014, 9:115-125.
6. Anderson SJ, Cherutich P, Kilonzo N, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet 2014, 384:249-256.
7. Grabowski MK, Redd AD Molecular tools for studying HIV transmission in sexual networks. Curr Opin HIV AIDS 2014, 9:126-133.
8. Campbell MS, Mullins JI, Hughes JP, et al. Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLoS One 2011, 6:e16986.
9. Brenner BG, Roger M, Routy JP, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007, 195:951-959.
10. Frange P, Meyer L, Deveau C, et al. Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency. PLoS One 2012, 7:e31695.
11. Hue S, Pillay D, Clewley JP, Pybus OG Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc Natl Acad Sci USA 2005, 102:4425-4429.
12. Hughes GJ, Fearnhill E, Dunn D, et al. Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog 2009, 5:e1000590.
13. Fisher M, Pao D, Brown AE, et al. Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach. AIDS 2010, 24:1739-1747.
14. de Oliveira T, Shafer RW, Seebregts C Public database for HIV drug resistance in southern Africa. Nature 2010, 464:673.
15. Ending overly broad criminalization of HIV non-disclosure, exposure and transmission: critical scientific, medical and legal considerations 2013, UNAIDS, Joint United Nations Programme on HIV/AIDS, Geneva.